Delayed puberty versus hypogonadism: a challenge for the pediatrician
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Constitutional delay of growth and puberty (CDGP) is the most common cause of delayed puberty (DP), is mainly found in males, and is characterized by short stature and delayed skeletal maturation. A family history of the subject comprising the timing of puberty in the parents and physical examination may provide clues regarding the cause of DP. Delayed onset of puberty is rarely considered a disease in either sex. In fact, DP usually represents a common normal variant in pubertal timing, with favorable outcomes for final height and future reproductive capacity. In adolescents with CDGP, a linear growth delay occurs until immediately before the start of puberty, then the growth rate rapidly increases. Bone age is often delayed. CDGP is a diagnosis of exclusion; therefore, alternative causes of DP should be considered. Functional hypogonadotropic hypogonadism may be observed in patients with transient delay in hypothalamic-pituitary-gonadal axis maturation due to associated conditions including celiac disease, inflammatory bowel diseases, kidney insufficiency, and anorexia nervosa. Permanent hypogonadotropic hypogonadism (pHH) showing low serum value of testosterone or estradiol and blunted follicle-stimulating hormones (FSH) and luteinizing hormones (LH) levels may be due to abnormalities in the central nervous system. Therefore, magnetic resonance imaging is necessary to exclude morphological abnormalities and neoplasia. Moreover, pHH may be isolated, as observed in Kallmann syndrome, or associated with other hormone deficiencies, as found in panhypopituitarism. Baseline or gonadotropin-releasing hormone pituitary stimulated gonadotropin level is not sufficient to easily differentiate CDGP from pHH. Low serum testosterone in male patients and low estradiol values in female patients, associated with high serum FSH and LH levels, suggest a diagnosis of hypergonadotropic hypogonadism. A genetic analysis can reveal a chromosomal abnormality (e.g., Turner syndrome or Klinefelter syndrome). In cases where the adolescent with CDGP is experiencing psychological difficulties, treatment should be recommended.
Abstract
Constitutional delay of growth and puberty (CDGP) is the most common cause of delayed puberty (DP), is mainly found in males, and is characterized by short stature and delayed skeletal maturation. A family history of the subject comprising the timing of puberty in the parents and physical examination may provide clues regarding the cause of DP. Delayed onset of puberty is rarely considered a disease in either sex. In fact, DP usually represents a common normal variant in pubertal timing, with favorable outcomes for final height and future reproductive capacity. In adolescents with CDGP, a linear growth delay occurs until immediately before the start of puberty, then the growth rate rapidly increases. Bone age is often delayed. CDGP is a diagnosis of exclusion; therefore, alternative causes of DP should be considered. Functional hypogonadotropic hypogonadism may be observed in patients with transient delay in hypothalamic-pituitary-gonadal axis maturation due to associated conditions including celiac disease, inflammatory bowel diseases, kidney insufficiency, and anorexia nervosa. Permanent hypogonadotropic hypogonadism (pHH) showing low serum value of testosterone or estradiol and blunted follicle-stimulating hormones (FSH) and luteinizing hormones (LH) levels may be due to abnormalities in the central nervous system. Therefore, magnetic resonance imaging is necessary to exclude morphological abnormalities and neoplasia. Moreover, pHH may be isolated, as observed in Kallmann syndrome, or associated with other hormone deficiencies, as found in panhypopituitarism. Baseline or gonadotropin-releasing hormone pituitary stimulated gonadotropin level is not sufficient to easily differentiate CDGP from pHH. Low serum testosterone in male patients and low estradiol values in female patients, associated with high serum FSH and LH levels, suggest a diagnosis of hypergonadotropic hypogonadism. A genetic analysis can reveal a chromosomal abnormality (e.g., Turner syndrome or Klinefelter syndrome). In cases where the adolescent with CDGP is experiencing psychological difficulties, treatment should be recommended.
참고문헌 (21)
- Wu FC, "Ontogeny of pulsatile gonadotropin releasing hormone secretion from midchildhood, through puberty, to adulthood in the human male: a study using deconvolution analysis and an ultrasensitive immunofluorometric assay", J Clin Endocrinol Metab, 81, pp.1798~1805 (1996)
- Marshall WA, "Variations in the pattern of pubertal changes in boys", Arch Dis Child, 45, pp.13~23 (1970)[DOI]
- Marshall WA, "Variations in pattern of pubertal changes in girls", Arch Dis Child, 44, pp.291~303 (1969)[DOI]
- Wehkalampi K, "Patterns of inheritance of constitutional delay of growth and puberty in families of adolescent girls and boys referred to specialist pediatric care", J Clin Endocrinol Metab, 93, pp.723~728 (2008)[DOI]
- LaFranchi S, "Constitutional delay of growth: expected versus final adult height", Pediatrics, 87, pp.82~87 (1991)
- Rohani F, "Evaluation of near final height in boys with constitutional delay in growth and puberty", Endocr Connect, 7, pp.456~459 (2018)[DOI]
- Hayes FJ, "Hypogonadotropic hypogonadism", Endocrinol Metab Clin North Am, 27, pp.739~763 (1998)[DOI]
- Bhagavath B, "Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism", Fertil Steril, 85, pp.706~713 (2006)[DOI]
- Bianco SD, "The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism", Nat Rev Endocrinol, 5, pp.569~576 (2009)[DOI]
- Gajdos ZK, "Genetic determinants of pubertal timing in the general population", Mol Cell Endocrinol, 324, pp.21~29 (2010)[DOI]
- Copeland KC, "Mini-puberty and growth", pediatrics, 138, pp.e20161301~ (2016)[DOI]
- Lanes R, "Effectiveness and limitations of the use of the gonadotropin-releasing hormone agonist leuprolide acetate in the diagnosis of delayed puberty in males", Horm Res, 48, pp.1~4 (1997)[DOI]
- Odink RJ, "Predictive value of serum folliclestimulating hormone levels in the differentiation between hypogonadotropic hypogonadism and constitutional delay of puberty", Horm Res, 49, pp.279~287 (1998)
- Smals AG, "Predictive value of luteinizing hormone releasing hormone (LHRH) bolus testing before and after 36-hour pulsatile LHRH administration in the differential diagnosis of constitutional delay of puberty and male hypogonadotropic hypogonadism", J Clin Endocrinol Metab, 78, pp.602~608 (1994)
- Kletter GB, "Gonadotropin-releasing hormone agonist analog (nafarelin): a useful diagnostic agent for the distinction of constitutional growth delay from hypogonadotropic hypogonadism", J Pediatr Endocrinol Metab, 9, pp.9~19 (1996)
- Zamboni G, "Use of the gonadotropinreleasing hormone agonist triptorelin in the diagnosis of delayed puberty in boys", J Pediatr, 126(5), pp.756~758 (1995)[DOI]
- Wilson DA, "Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty", J Pediatr, 148, pp.89~94 (2006)[DOI]
- Puett D, "A functional transmembrane complex: the luteinizing hormone receptor with bound ligand and G protein", Mol Cell Endocrinol, 260-262, pp.126~136 (2007)[DOI]
- Dunkel L, "GnRH and HCG tests are both necessary in differential diagnosis of male delayed puberty", Am J Dis Child, 139, pp.494~498 (1985)
- Coutant R, "Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty", J Clin Endocrinol Metab, 95, pp.5225~5232 (2010)[DOI]
- Dwyer AA, "Management of endocrine disease: reversible hypogonadotropic hypogonadism", Eur J Endocrinol, 174, pp.R267~R274 (2016)[DOI]